Cardiovascular drugs market covers the drugs used to treat conditions that affect the heart or blood vessels. These conditions include heart stroke, coronary artery diseases, valvular diseases, peripheral venous diseases, pericarditis, endocarditis, cardiac tumors, arteriosclerosis, and lymphatic diseases. Some of the major cardiovascular drugs include anti-hypertensive drugs such as calcium channel blockers and Angiotensin II receptor antagonists, and hypolipidemic drugs such as fibric acid derivatives and bile acid binding resins.
The market numbers within this briefing are restricted to pharmaceutical (drug) treatments and do not cover biologic treatments for these conditions which are included in a separate briefing.
The Cardiovascular Drugs Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs market.
The Cardiovascular Drugs Market Global Briefing 2018 from The Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.
The market characteristics section of the report defines and explains the market.
The market size section gives the cardiovascular drugs market revenues, covering both the historic growth of the market and forecasting the future.
Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.
The trends and strategies section highlights the likely future developments in the cardiovascular drugs market and suggests approaches.
Reasons To Purchase
- Fully updated for 2018.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.
Markets Covered: Cardiovascular Drugs, Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases.
Companies Mentioned: Medtronic Plc, Abbott Laboratories Inc. and Boston Scientific Corporation
Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East and Africa.
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
Table of Contents
Cardiovascular Drugs Market Characteristics 5
Cardiovascular Drugs Market Historic Growth (2013-17) 7
Cardiovascular Drugs Market Forecast Growth (2017-21) 8
Cardiovascular Drugs Market Segmentation 9
Global Cardiovascular Drugs Market, Split By Segments, 2017, $ Billion 9
Anti-hypertensive Drugs 10
Anti Thrombotics 10
Global Cardiovascular Drugs Market, Historic and Forecast, Split By Segments, 2013-2021 11
Cardiovascular Drugs Market Geography Regional and Country Comparison 13
Global Cardiovascular Drugs Market, Split By Regions, 2017 13
Global Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021 15
Global Cardiovascular Drugs Market, Split By Country, 2017 17
Global Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021 19
Cardiovascular Drugs Market Competitive Landscape 21
Merck & Co. 22
Sanofi S.A. 22
Pfizer Inc. 22
Bristol-Myers Squibb Company 22
Novartis AG 22
Eli Lilly And Company 22
Johnson & Johnson 22
AstraZeneca Plc. 22
Abbott Laboratories Inc. 22
Bayer AG 22
Merck & Co. 23
Cardiovascular Drugs Market Key Mergers And Acquisitions 25
Teva Acquired Allergan’s Generic Business 25
Pfizer Acquired Hospira 25
AstraZeneca Acquired ZS Pharma 25
AstraZeneca Acquired Omthera Pharmaceuticals 25
Bristol-Myers Squibb Acquired Cardioxyl Pharmaceuticals 25
Cardiovascular Drugs Market Trends And Strategies 26
Novel Oral Anti-coagulants (NOACs) To Prevent Thrombosis 26
Approval Of New Drugs For Treatment Of Chronic Heart Failure 26
Personalized Medicine For Treatment Of Cardiovascular Disorders 26
Big Data 26
NAICS Definitions Of Industry Covered In This Report 28
Definition Of Market Covered In This Report 28
Research Methodology 29
Research Inquiries 30
The Business Research Company 30
The Business Research Company
47 Anchorage Point,
42 Cuba Street, Canary Wharf,
+44 207 1930 708